Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study

OBJECTIVE: In this pilot clinical study, we report the beneficial effects of beta glucans derived from two strains AFO-202 and N-163 of a black yeast Aureobasidium pullulans on the biomarkers for cytokine storm and coagulopathy in COVID-19 patients. METHODS: A total of 24 RT-PCR positive COVID-19 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghavan, Kadalraja, Dedeepiya, Vidyasagar Devaprasad, Suryaprakash, Vaddi, Rao, Kosagi-Sharaf, Ikewaki, Nobunao, Sonoda, Tohru, Levy, Gary A., Iwasaki, Masaru, Senthilkumar, Rajappa, Preethy, Senthilkumar, Abraham, Samuel JK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463314/
https://www.ncbi.nlm.nih.gov/pubmed/34840031
http://dx.doi.org/10.1016/j.biopha.2021.112243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463314/
https://www.ncbi.nlm.nih.gov/pubmed/34840031
http://dx.doi.org/10.1016/j.biopha.2021.112243

Ejemplares similares